Skip to main content
. 2023 Jun 24;29(7):1782–1792. doi: 10.1038/s41591-023-02427-z

Extended Data Fig. 2. Effect of pegozafermin on serum TGs by subgroup.

Extended Data Fig. 2

Shown are the 95% CIs for median differences. If the percentage of participants within a subgroup was less than 33% of the overall cohort (n < 6), only descriptive analysis is presented. LMT, lipid modifying therapy; PGZ, pegozafermin.